Global Andersen-Tawil Syndrome Market, By Type (Diagnosis, Treatment), Related Disorders (QT Syndrome, Periodic Paralysis, Others), End User (Hospitals, Specialty Clinics, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Andersen-Tawil Syndrome Market
Global Andersen-Tawil Syndrome market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 7.20% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
However, the increasing prevalence of Andersen-Tawil Syndrome also boosts up the market growth. Moreover, rising advancements in diagnosis & treatment and the rise in government prioritization of drugs for rare disorders also boost up the market growth. But, lack of awareness of the disorders in developing countries and till now no approved treatment for the disorders may hamper the global Andersen-Tawil Syndrome market.
Andersen-Tawil Syndrome is a rare genetic disorder identified by paralysis (periodic) and episodes of muscle weakness. The abnormalities affect the electrical system of the heart which causes abnormal heart rhythms known as arrhythmias and a variety of distinctive facial and skeletal features. It is stated that approximately 60% of cases are caused by a mutation in the KCNJ2 gene and 40% of cases underlying genetic mutation are unknown. Moreover, 50% of cases occur sporadically that the mutation occurs during the pregnancy. The disorder does not pass through family members.
Andersen-Tawil Syndrome affects both males and females equally, the exact prevalence and incidence of the disorder are unknown. Over, more than 100 cases have been reported in the medical literature.
This Andersen-Tawil Syndrome market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Andersen-Tawil Syndrome Market Scope and Market Size
The Andersen-Tawil Syndrome market is segmented on the basis of type, related disorders, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the Andersen-Tawil Syndrome market is segmented into diagnosis and treatment. Diagnosis segment is further divided into blood test, ECG, EKG, molecular genetic testing and others. Treatment segment is further divided into medication, Surgery, occupational therapy and others. Medication further divided into potassium oral supplements, carbonic anhydrase inhibitors, anti-arrhythmic and others. Surgery segment further divided into automatic cardioverter-defibrillator, ICD and others. Occupational therapy further segmented into physical therapy, speech therapy and others.
- On the basis of related disorders, the Andersen-Tawil Syndrome market is segmented into QT syndrome, periodic paralysis and others.
- On the basis of end users, the Andersen-Tawil Syndrome market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the Andersen-Tawil Syndrome market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Andersen-Tawil Syndrome Market Country Level Analysis
Andersen-Tawil Syndrome market is analysed and market size information is provided by country, type, related disorders, end-users and distribution channel as referenced above.
The countries covered in the Andersen-Tawil Syndrome market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the increase in research and development and favourable reimbursement policies. Europe accounts the second largest market share due to presence of refined healthcare facilities. Asia-Pacific is expected to account for the largest market share over coming years for the Andersen-Tawil Syndrome market due to increased advancement in the technology as well as growing healthcare expenditure and rising awareness program.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Andersen-Tawil Syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Andersen-Tawil Syndrome Market Share Analysis
Andersen-Tawil Syndrome market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Andersen-Tawil Syndrome market.
The major players covered in the Andersen-Tawil Syndrome market are Aurobindo Pharma, Zydus Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Novartis AG, Viatris Inc., Advanz Pharmaceutical among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-